All Stories

  1. Fluid Restriction for Patients with Heart Failure: Current Evidence and Future Perspectives
  2. Why should a national cardiology society affiliate with the Association of Cardiovascular Nursing and Allied Professions?
  3. Changes over time in patient‐reported outcomes in patients with heart failure
  4. Psychometric properties of the Japanese version of the Self-Care of Heart Failure Index version 7.2
  5. Adaptación cultural del Cuestionario de autocuidado en pacientes con asistencia ventricular definitiva
  6. Validity and reliability of the left ventricular assist device self-care behaviour scale
  7. Globe is Still Heterogenous from the Perspective of Heart Failure
  8. Factors associated with lack of improvement in submaximal exercise capacity of patients with heart failure
  9. Methodological quality of studies assessing validity and reliability of the European Heart Failure Self-care Behaviour Scale: a systematic review using the COSMIN methodology
  10. The consequences of the COVID‐19 pandemic for self‐care in patients supported with a left ventricular assist device
  11. Trajectory of self-care behaviour in patients with heart failure: the impact on clinical outcomes and influencing factors
  12. Psychometric Testing of the Hebrew Version of the European Heart Failure Self-Care Behaviour Scale
  13. Development of an Instrument for Measuring Self-Care Behaviors After Left Ventricular Assist Device Implantation
  14. Thirst in Patients With Heart Failure in Sweden, the Netherlands, and Japan
  15. Quality of life of family caregivers of patients with a left ventricular assist device in Japan
  16. Development and psychometric evaluation of the Thirst Distress Scale for patients with heart failure
  17. Health literacy is independently associated with self-care behavior in patients with heart failure
  18. How effective is an in-hospital heart failure self-care program in a Japanese setting? Lessons from a randomized controlled pilot study
  19. Development and Validation of a Heart Failure–Specific Health Literacy Scale
  20. High Dose β-Blocker Therapy Triggers Additional Reverse Remodeling in Patients With Idiopathic Non-Ischemic Cardiomyopathy
  21. Heart Failure Telemonitoring in Japan and Sweden: A Cross-Sectional Survey
  22. Quality of Life and Influential Factors in Patients Implanted With a Left Ventricular Assist Device
  23. Corrigendum to “Differential impacts of achieved heart rate and achieved dose of β-blocker on clinical outcomes in heart failure with and without atrial fibrillation”[Int. J. Cardiol. 173 (2) (2014) 331–3]
  24. Learning Self-care After Left Ventricular Assist Device Implantation
  25. Differential impacts of achieved heart rate and achieved dose of β-blocker on clinical outcomes in heart failure with and without atrial fibrillation
  26. Impact of Comorbidities on Economic and Health Outcomes for Patients With Cardiovascular Disease
  27. Late-Onset Right Ventricular Failure in Patients With Preoperative Small Left Ventricle After Implantation of Continuous Flow Left Ventricular Assist Device
  28. Urine Sodium Excretion After Tolvaptan Administration Is Dependent Upon Baseline Serum Sodium Levels
  29. A Randomized Controlled Pilot Study of the Japanese Heart Failure Self-Management Program: Impacts on Heart Failure Knowledge and Clinical Outcomes
  30. Is Achieved Heart Rate a Surrogate Maker during Titration of Beta-blocker in Heart Failure with Atrial Fibrillation?
  31. Psychometric Testing of the Japanese Version of the Self-Care of Heart Failure Index
  32. Comparison of self-care behaviors of heart failure patients in 15 countries worldwide
  33. Acute pulmonary vasoreactivity test with sildenafil or nitric monoxide before left ventricular assist device implantation
  34. A Case With Recovery of Response to Tolvaptan Associated With Remission of Acute Kidney Injury and Increased Urine Osmolality
  35. Novel Criteria of Urine Osmolality Effectively Predict Response to Tolvaptan in Decompensated Heart Failure Patients
  36. Preoperative Levels of Bilirubin or Creatinine Adjusted by Age Can Predict Their Reversibility After Implantation of Left Ventricular Assist Device
  37. Successful Conversion From Thiazide to Tolvaptan in a Patient With Stage D Heart Failure and Chronic Kidney Disease Before Heart Transplantation
  38. Successful Treatment of Hemodynamic Compromise Caused by Antibody-Mediated and Cellular Rejection in a Recipient 12 years After Heart Transplantation
  39. Trend of Clinical Outcome and Surrogate Markers During Titration of ^|^beta;-Blocker in Heart Failure Patients With Reduced Ejection Fraction
  40. Urine Osmolality Estimated Using Urine Urea Nitrogen, Sodium and Creatinine Can Effectively Predict Response to Tolvaptan in Decompensated Heart Failure Patients
  41. An elevated ratio of early to late diastolic filling velocity recovers after heart transplantation in a time-dependent manner
  42. Quality of Life as a Surrogate Marker to Predict Cardiac Events in Heart Failure with Reduced and Preserved Ejection Fraction
  43. Bosentan improved persistent pulmonary hypertension in a case after implantation of a left ventricular assist device
  44. How to demonstrate the reversibility of end-organ function before implantation of left ventricular assist device in INTERMACS profile 2 patients?
  45. Depressive symptoms are common and associated with adverse clinical outcomes in heart failure with reduced and preserved ejection fraction
  46. Development of self-care educational material for patients with heart failure in Japan: a pilot study
  47. Combination Evaluation of Preoperative Risk Indices Predicts Requirement of Biventricular Assist Device
  48. Novel Risk Scoring System With Preoperative Objective Parameters Gives a Good Prediction of 1-Year Mortality in Patients With a Left Ventricular Assist Device
  49. Successful Conversion to Everolimus After Cytomegalovirus Infection in a Heart Transplant Recipient
  50. Symptom-Monitoring and Treatment-Seeking Behaviors in Japanese Patients with Heart Failure: A Multicenter Study
  51. Translation and Validation Study of the Japanese Versions of the Coronary Revascularisation Outcome Questionnaire (CROQ-J)
  52. Age and Preoperative Total Bilirubin Level Can Stratify Prognosis After Extracorporeal Pulsatile Left Ventricular Assist Device Implantation
  53. Knowledge and Demand for Information about Islet Transplantation in Patients with Type 1 Diabetes
  54. Less Frequent Opening of the Aortic Valve and a Continuous Flow Pump Are Risk Factors for Postoperative Onset of Aortic Insufficiency in Patients With a Left Ventricular Assist Device
  55. Quality of Life as an Independent Predictor for Cardiac Events and Death in Patients With Heart Failure
  56. Could Pimobendan Improve Clinical Outcomes of Patients With Chronic Heart Failure?
  57. Validity and Reliability of Seattle Angina Questionnaire Japanese Version in Patients With Coronary Artery Disease
  58. Relationship of Depressive Symptoms With Hospitalization and Death in Japanese Patients With Heart Failure
  59. Adherence to self-care behavior and factors related to this behavior among patients with heart failure in Japan
  60. Carvedilol Improves Clinical Outcomes in Heart Failure With Preserved Ejection Fraction (HFpEF) as Well as Reduced Ejection Fraction (HFrEF)
  61. Importance of Enhancing Self-Care Behavior in Patients With Chronic Heart Failure to Prevent Re-hospitalization for Worsening Heart Failure
  62. Preventive advice given by patients with type 2 diabetes to their offspring
  63. Validity and Reliability of the Japanese Version of the European Heart Failure Self-Care Behavior Scale
  64. Depression is an independent predictor of hospitalization in outpatients with heart failure
  65. Factors Associated with Self-Care Behavior of Heart Failure Patients Assessed with the European Heart Failure Self-Care Behavior Scale Japanese Version